South Korea
· Delayed Price · Currency is KRW Anterogen.Co.,Ltd. Statistics
Total Valuation
Anterogen.Co.,Ltd. has a market cap or net worth of KRW 141.30 billion. The enterprise value is 100.74 billion.
| Market Cap | 141.30B |
| Enterprise Value | 100.74B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Anterogen.Co.,Ltd. has 9.73 million shares outstanding. The number of shares has decreased by -0.07% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 9.73M |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 15.09% |
| Owned by Institutions (%) | 0.60% |
| Float | 7.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.21 |
| PB Ratio | 1.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -43.54 |
| EV / Sales | 15.13 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -522.05 |
Financial Position
The company has a current ratio of 45.24
| Current Ratio | 45.24 |
| Quick Ratio | 43.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.22 |
Financial Efficiency
Return on equity (ROE) is -1.99% and return on invested capital (ROIC) is -2.03%.
| Return on Equity (ROE) | -1.99% |
| Return on Assets (ROA) | -1.95% |
| Return on Capital (ROIC) | -2.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.05 |
| Inventory Turnover | 2.51 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.83% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +6.83% |
| 50-Day Moving Average | 14,817.60 |
| 200-Day Moving Average | 14,798.05 |
| Relative Strength Index (RSI) | 41.92 |
| Average Volume (20 Days) | 12,170 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Anterogen.Co.,Ltd. had revenue of KRW 6.66 billion and -2.31 billion in losses. Loss per share was -237.85.
| Revenue | 6.66B |
| Gross Profit | 2.74B |
| Operating Income | -3.92B |
| Pretax Income | -2.31B |
| Net Income | -2.31B |
| EBITDA | -3.16B |
| EBIT | -3.92B |
| Loss Per Share | -237.85 |
Balance Sheet
| Cash & Cash Equivalents | 40.56B |
| Total Debt | n/a |
| Net Cash | 40.56B |
| Net Cash Per Share | 4,167.83 |
| Equity (Book Value) | 114.75B |
| Book Value Per Share | 11,791.41 |
| Working Capital | 44.86B |
Cash Flow
In the last 12 months, operating cash flow was -9.05 million and capital expenditures -183.92 million, giving a free cash flow of -192.97 million.
| Operating Cash Flow | -9.05M |
| Capital Expenditures | -183.92M |
| Free Cash Flow | -192.97M |
| FCF Per Share | -19.83 |
Margins
Gross margin is 41.18%, with operating and profit margins of -58.92% and -34.75%.
| Gross Margin | 41.18% |
| Operating Margin | -58.92% |
| Pretax Margin | -34.75% |
| Profit Margin | -34.75% |
| EBITDA Margin | -47.47% |
| EBIT Margin | -58.92% |
| FCF Margin | -2.90% |
Dividends & Yields
Anterogen.Co.,Ltd. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.07% |
| Shareholder Yield | 0.07% |
| Earnings Yield | -1.64% |
| FCF Yield | -0.14% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Anterogen.Co.,Ltd. has an Altman Z-Score of 23.61.
| Altman Z-Score | 23.61 |
| Piotroski F-Score | n/a |